Drug details

Intuniv (guanfacine)

type of CNS Stimulants, Anorexiants

Intuniv (guanfacine) is an alpha-2 adrenergic agonist used to treat attention deficit hyperactivity disorder (ADHD) in patients older than 6 years of age, as part of a total treatment plan including psychological, educational, and social measures. Unlike other drugs used to treat ADHD, Intuniv is not a stimulant. Intuniv is also used to treat high blood pressure (hypertension) and is often given together with other blood pressure medications.

This drug may have the following side effects:
  • lightheadedness,
  • confusion,
  • severe drowsiness,
  • nervousness,
  • headaches,
  • anxiety,
  • tremors,
  • rapid heartbeats,
  • vision problems, and
  • slow heartbeats,
  • hallucinations (especially in children),
  • increased or very high blood pressure,
  • convulsions (seizures)
The following drugs are related to Intuniv, either as a replacement or used together:
  • Adderall (amphetamine, dextroamphetamine mixed salts)
  • Adderall XR (amphetamine, dextroamphetamine mixed salts)
  • Evekeo ODT (amphetamine sulfate orally disintegrating tablets)
  • Aptensio XR (methylphenidate hydrochloride extended-release capsules)
  • Strattera (atomoxetine hcl)
  • Azstarys (serdexmethylphenidate and dexmethylphenidate capsules)
  • Celexa (citalopram hydrobromide)
  • Concerta (methylphenidate extended-release tablets)
  • Focalin XR (dexmethylphenidate hydrochloride)
  • Focalin (dexmethylphenidate hydrochloride)
  • Lexapro (escitalopram oxalate)
  • Prozac (fluoxetine hcl)
  • Jornay PM (methylphenidate hydrochloride extended-release capsules)
  • Vyvanse (lisdexamfetamine dimesylate)
  • Methyldopa Tablets (methyldopa)
  • Quillivant XR (methylphenidate hydrochloride extended release oral suspension, cii)
  • Nipride RTU (sodium nitroprusside injection)
  • Qelbree (viloxazine extended-release capsules)